PMC10092242_01
Flow diagram of the pathways associated with skin sensitization
COD-88-35-g003.jpg
PMC10092242_01_COD-88-35-g003.jpg
cod14216-fig-0001
The first phase includes a sequential set of events which are described in the Adverse Outcome Pathway (AOP) no. 40 (https://aopwiki.org/wiki/index.php/Aop:40) as shown in Figure 1 taken from Strickland et al. 